GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins …
[Read the full article here]Related News:
Stem Cell And Neurobiology Expert Clive Svendsen, Ph.D. Joins Cedars-Sinai To Head New Regenerative Medicine Institute
Pfizer, University College London enter pact to develop stem cell-based therapies
From stem cells to new organs: Stanford and NYU scientists cross threshold in regenerative medicine